The evolution of plasmid-carried antibiotic resistance

BMC Evolutionary Biology

Daniel J Rankin²  Fabian Svara¹ 

[1] Institute of Evolutionary Biology and Environmental Studies, University of Zürich, Building Y27, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland;Swiss Institute of Bioinformatics, Quartier Sorge, Bâtiment Génopode, CH-1015 Lausanne, Switzerland

关键词: mobile elements;    horizontal gene transfer;    antibiotic;    resistance;    plasmid;   

Others  :  1144291
DOI  :  10.1186/1471-2148-11-130

 received in 2010-10-25, accepted in 2011-05-19,  发布年份 2011

【 摘 要 】

Background

Antibiotic resistance represents a significant public health problem. When resistance genes are mobile, being carried on plasmids or phages, their spread can be greatly accelerated. Plasmids in particular have been implicated in the spread of antibiotic resistance genes. However, the selective pressures which favour plasmid-carried resistance genes have not been fully established. Here we address this issue with mathematical models of plasmid dynamics in response to different antibiotic treatment regimes.

Results

We show that transmission of plasmids is a key factor influencing plasmid-borne antibiotic resistance, but the dosage and interval between treatments is also important. Our results also hold when plasmids carrying the resistance gene are in competition with other plasmids that do not carry the resistance gene. By altering the interval between antibiotic treatments, and the dosage of antibiotic, we show that different treatment regimes can select for either plasmid-carried, or chromosome-carried, resistance.

Conclusions

Our research addresses the effect of environmental variation on the evolution of plasmid-carried antibiotic resistance.

【 授权许可】

   
2011 Svara and Rankin; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]WHO: Overcoming antibiotic resistance. In World Health Organisation Report in Infectious Disease. Geneva: World Health Organisation; 2000.
• [2]Lipsitch M, Bergstrom CT: Modeling of antibiotic resistance in the ICU - U.S. slant. In Infection control in the ICU environment. Edited by Weinstein RA. Bonten M: Kluwer; 2002.
• [3]Bergstrom CT, Feldgarden M: The ecology and evolution of antibiotic-resistant bacteria. In Evolution in Health and Disease. 2nd edition. Edited by Stearns S, Koella J. Oxford: Oxford University Press; 2008.
• [4]Lipsitch M: The rise and fall of antimicrobial resistance. Trends in Microbiology 2001, 9(9):438-444.
• [5]Lipsitch M, Samore MH: Antimicrobial use and antimicrobial resistance: a population perspective. Emerging Infectious Diseases 2002, 8(4):347-354.
• [6]Thomas CM, Nielsen KM: Mechanisms of, and Barriers to, Horizontal Gene Transfer between Bacteria. Nat Rev Micro 2005, 3(9):711-721.
• [7]Falkow S, Citarella RV, Wohlhieter JA, Watanabe T: The molecular nature of R-factors. Journal of Molecular Biology 1966, 17(1):102-116.
• [8]Sugino Y, Hirota Y: Conjugal fertility associated with resistance factor R in Escherichia coli. Journal of Bacteriology 1962, 84(5):902-910.
• [9]Clewell DB, Yagi Y, Bauer B: Plasmid-determined tetracycline resistance in Streptococcus faecalis: evidence for gene amplification during growth in presence of tetracycline. Proceedings of the National Academy of Sciences 1975, 72:1720-1724.
• [10]Livermore DM: Beta-Lactamases in laboratory and clinical resistance. Clinical Microbiolologocal Reviews 1995, 8(4):557-584.
• [11]Johnsen PJ, Simonsen GS, Olsvik O, Midtvedt T, Sundsfjord A: Stability, persistence, and evolution of plasmid-encoded VanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in mice. Microbial Drug Resistance 2002, 8:161-170.
• [12]Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC: Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus. Science 2003, 302(5650):1569-1571.
• [13]Furuya EY, Lowy FD: Antimicrobial-resistant bacteria in the community setting. Nat Rev Micro 2006, 4(1):36-45.
• [14]Robicsek A, Jacoby GA, Hooper DC: The worldwide emergence of plasmid-mediated quinolone resistance. The Lancet Infectious Diseases 2006, 6:629-640.
• [15]Dionisio F, Matic I, Radman M, Rodrigues OR, Taddei F: Plasmids spread very fast in heterogeneous bacterial communities. Genetics 2002, 162(4):1525-1532.
• [16]Hughes VM, Datta N: Conjugative plasmids in bacteria of the 'pre-antibiotic' era. Nature 1983, 302(5910):725-726.
• [17]Turner PE, Cooper VS, Lenski RE: Tradeoff between horizontal and vertical modes of transmission in bacterial plasmids. Evolution 1998, 52(2):315-329.
• [18]Bergstrom CT, Lipsitch M, Levin BR: Natural selection, infectious transfer and the existence conditions for bacterial plasmids. Genetics 2000, 155:1505-1519.
• [19]Lili LN, Britton NF, Feil EJ: The persistence of parasitic plasmids. Genetics 2007, 177(1):399-405.
• [20]Rankin DJ, Rocha EPC, Brown SP: What genes are carried on mobile elements, and why? Heredity 2011, 106:1-10.
• [21]Levin BR, Stewart FM: Probability of establishing chimeric plasmids in natural populations of bacteria. Science 1977, 196:218-220.
• [22]Stewart FM, Levin BR: The population biology of bacterial plasmids: a priori conditions for the existence of conjugationally transmitted factors. Genetics 1977, 87:209-228.
• [23]Anderson RM, May RM: Population biology of infectious diseases: Part I. Nature 1979, 280(5721):361-367.
• [24]Anderson RM, May RM: Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press; 1992.
• [25]May RM, Anderson RM: Population biology of infectious diseases: Part II. Nature 1979, 280(5722):455-461.
• [26]Smith J: The social evolution of bacterial pathogenesis. Proceedings of the Royal Society of London Series B-Biological Sciences 2001, 268:61-69.
• [27]Dionisio F, Conceicao IC, Marques ACR, Fernandes L, Gordo I: The evolution of a conjugative plasmid and its ability to increase bacterial fitness. Biology Letters 2005, 1(2):250-252.
• [28]Yates CM, Shaw DJ, Roe AJ, Woolhouse MEJ, Amyes SGB: Enhancement of bacterial competitive fitness by apramycin resistance plasmids from non-pathogenic Escherichia coli. Biology Letters 2006, 2(3):463-465.
• [29]Ellis RJ, Lilley AK, Lacey SJ, Murrell D, Godfray HCJ: Frequency-dependent advantages of plasmid carriage by Pseudomonas in homogeneous and spatially structured environments. Isme J 2007, 1(1):92-95.
• [30]Slater FR, Bailey MJ, Tett AJ, Turner SL: Progress towards understanding the fate of plasmids in bacterial communities. FEMS Microbiol Ecology 2008, 66:3-13.
• [31]Nogueira T, Rankin DJ, Touchon M, Taddei F, Brown SP, Rocha EP: Gene mobility drives the evolution of bacterial cooperation and virulence. Current Biology 2009, 19:1683-1691.
• [32]Lenski RE: Bacterial evolution and the cost of antibiotic resistance. International Microbiology 1998, 1:265-270.
• [33]Andersson DI, Levin BR: The biological cost of antibiotic resistance. Current Opinion in Microbiology 1999, 2(5):489-493.
• [34]Björkman J, Nagaev I, Berg OG, Hughes D, Andersson DI: Effects of Environment on Compensatory Mutations to Ameliorate Costs of Antibiotic Resistance. Science 2000, 287(5457):1479-1482.
• [35]Schrag SJ, Perrot V, Levin BR: Adaptation to the Fitness Costs of Antibiotic Resistance in Escherichia coli. Proceedings: Biological Sciences 1997, 264(1386):1287-1291.
• [36]Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJM: The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis. Science 2006, 312(5782):1944-1946.
• [37]Andersson DI: The biological cost of mutational antibiotic resistance: any practical conclusions? Current Opinion in Microbiology 2006, 9:461-465.
• [38]Rankin DJ, Bichsel M, Wagner A: Mobile DNA can drive lineage extinction in prokaryotic populations. Journal of Evolutionary Biology 2010, 23:2422-2341.
• [39]Mc Ginty SE, Rankin DJ, Brown SP: Horizontal gene transfer and the evolution of bacterial cooperation. Evolution 2011, 65:21-32.
• [40]Regoes R, Wiuff C, Zappala RM, Garner KN, Baquero F, Levin BR: Pharmacodynamic functions: a multiparameter approach to the design of anitbiotic treatment regimens. Antimicrobial Agents and Chemotherapy 2004, 48(10):3670-3676.
• [41]Lobner-Olesen A: Distribution of minichromosomes in individual Escherichia coli cells: implications for replication control. EMBO J 1999, 18(6):1712-1721.
• [42]Nordstrom K, Uhlin BE: Runaway-Replication Plasmids as Tools to Produce Large Quantities of Proteins from Cloned Genes in Bacteria. Nat Biotech 1992, 10(6):661-666.
• [43]Makrides SC: Strategies for Achieving High-Level Expression of Genes in Escherichia coli. Microbiological Reviews 1996, 60(3):512-538.
• [44]Morino T, Morita M, Seya K, Sukenaga Y, Kato K, Nakamura T: Construction of a runaway vector and its use for a high-level expression of a cloned human superoxide dismutase gene. Applied Microbiology and Biotechnology 1988, 28:170-175.
• [45]Andersson DI, Hughes D: Gene amplification and adaptive evolution in bacteria. Annual Review of Genetics 2009, 43:167-195.
• [46]Sandegren L, Andersson DI: Bacterial gene amplification: implications for the evolution of antibiotic resistance. Nat Rev Micro 2009, 7(8):578-588.
• [47]Sun S, Berg OG, Roth JR, Andersson DI: Contribution of Gene Amplification to Evolution of Increased Antibiotic Resistance in Salmonella typhimurium. Genetics 2009, 182:1183-1195.
• [48]Vinks A, Derendorf H, Mouton J, (eds): Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics. New York: Springer; 2011.
• [49]Andersson DI, Hughes D: Antibiotic resistance and its cost: is it possible to reverse resistance? Nature reviews Microbiology 2010, 8(4):260-271.
• [50]Sorensen SJ, Bailey M, Hansen LH, Kroer N, Wuertz S: Studying plasmid horizontal transfer in situ: a critical review. Nature reviews Microbiology 2005, 3(9):700-710.
• [51]Hausner M, Wuertz S: High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Applied and Environmental Microbiology 1999, 65(8):3710-3713.
• [52]Dahlberg C, Bergstrom M, Hermansson M: In Situ Detection of High Levels of Horizontal Plasmid Transfer in Marine Bacterial Communities. Applied and Environmental Microbiology 1998, 64(7):2670-2675.
• [53]Williams JJ, Hergenrother PJ: Exposing plasmids as the Achilles' heel of drug-resistant bacteria. Current Opinion in Chemical Biology 2008, 12(4):389-399.
• [54]Amabile-Cuevas CF, Heinemann JA: Shooting the messenger of antibiotic resistance: plasmid elimination as a counter-evolutionary tactic. Drug Discovery Today 2004, 9(11):465-467.
• [55]Bergstrom CT, Lo M, Lipsitch M: Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:13285-13290.
• [56]Willms AR, Roughan PD, Heinemann JA: Static recipient cells as reservoirs of antibiotic resistance during antibiotic therapy. Theoretical Population Biology 2006, 70(4):436-451.
• [57]Webber MA, Piddock LJV: The importance of efflux pumps in bacterial antibiotic resistance. Journal of Antimicrobial Chemotherapy 2003, 51(1):9-11.
• [58]Lenski R: Bacterial evolution and the cost of antibiotic resistance. International Microbiology 1998, 1:265-270.
• [59]Modi RI, Adams J: Coevolution in bacterial-plasmid populations. Evolution 1991, 43(3):656-667.
• [60]Dahlberg C, Chao L: Amelioration of the cost of conjugative plasmid carriage in Eshericha coli K12. Genetics 2003, 165:1641-1649.
• [61]Ehrlich P: Address in Pathology on Chemotherapeutics: Scientific Principles, Methods and Results. The Lancet 1913, 182:445-451.
• [62]Liu B, Pop M: ARDB-Antibiotic Resistance Genes Database. Nucleic Acids Research 2009, 37:D443-447.